Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2015-11-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
北京国枫律师事务所关于公司股票期权与限制性股票激励计划限制性股票第二个解锁期可解锁暨回购注销部分限制性股票相关事项的法律意见书
Board/Management Information Classification · 95% confidence The document is a legal opinion letter issued by Beijing Grandway Law Offices regarding the stock option and restricted stock incentive plan of SanNuo Biological Sensing Co., Ltd. It specifically addresses the second unlocking period of restricted stocks and the repurchase and cancellation of some restricted stocks. The document includes detailed legal analysis, references to company resolutions, audit reports, and compliance with relevant laws and regulations. It is not a financial report, earnings release, or regulatory filing but a legal opinion related to management and governance matters concerning stock incentives. Therefore, it fits best under Board/Management Information (MANG) as it relates to management incentive plans and their legal validation.
2015-11-27 Chinese
关于回购注销部分限制性股票暨减资的债权人公告
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement by SanNuo Bio-sensing Co., Ltd. regarding the repurchase and cancellation of certain restricted shares and a related capital reduction. It includes details about the repurchase price, number of shares, and a creditor notice inviting creditors to declare their claims within a specified period. The document is relatively short (1337 characters) and serves as a formal notification to creditors about the company's stock repurchase and capital reduction process. It does not contain financial statements, detailed financial analysis, or management discussion. It is not an annual or interim report, nor a call transcript or earnings release. It is not a report publication announcement since it contains substantive information about the repurchase and creditor rights. The content fits best under the category of Share Issue/Capital Change (SHA), as it relates to changes in the company's capital structure through share repurchase and cancellation.
2015-11-27 Chinese
2015年第二次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and results of a specific shareholders' meeting (the 2015 second extraordinary general meeting) of the company. It details the legality and compliance of the meeting's call, attendance, voting procedures, and results. It does not contain financial statements, earnings data, or management discussion of financial results. It is not a report itself but a legal opinion related to a shareholders' meeting. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal procedural filing rather than a financial or management report.
2015-11-13 Chinese
2015年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a "2015 Second Extraordinary General Meeting Resolution Announcement" and details the resolutions passed at a shareholders' meeting, including voting results and legal opinions on the meeting's validity. It does not contain financial statements or detailed financial analysis but rather the official announcement of the voting outcomes and meeting proceedings. The document length is 4177 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2015-11-13 Chinese
关于召开2015年第二次临时股东大会的提示性公告
AGM Information Classification · 100% confidence The document is a detailed announcement about the convening of the 2015 second extraordinary general meeting of shareholders for the company 三诺生物传感股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be discussed and voted on, registration methods, and proxy authorization forms. The document does not contain financial statements or results but rather focuses on the logistics and agenda of the shareholder meeting. This matches the description of an AGM Information document, which includes presentations and materials shared during the Annual General Meeting or other shareholder meetings. The document is not a report of voting results, nor is it a proxy solicitation or a regulatory filing. Therefore, the correct classification is AGM Information (AGM-R). The document length (6779 characters) and content confirm it is a full announcement and not a brief notice or report publication announcement.
2015-11-09 Chinese
中信证券股份有限公司关于公司关联交易及对外担保的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed due diligence and verification opinion issued by CITIC Securities regarding related party transactions and external guarantees involving SanNuo Bio-sensing Co., Ltd. It discusses the company's strategic acquisition plans, related party transactions, guarantees, and approvals by the board and independent directors. The document is not a financial report, earnings release, or regulatory filing per se, but rather a formal verification opinion related to a specific transaction and guarantee. It does not contain financial statements or quarterly/yearly results. It is not a simple announcement or certification but a detailed verification opinion by the sponsor. This type of document fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other categories like M&A filings or capital updates directly, since it is a verification opinion on related party transactions and guarantees tied to an acquisition but not the acquisition announcement itself.
2015-10-27 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.